• SENSEX 73,285.75
    -312.92 (--0.43%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
Back

Results - Announcements

Medplus Health Services Ltd consolidated sales up 8.38% on year in Q3FY2026, net profit saw a strong growth of 69.04%
27-Oct-2026, 09:25

Medplus Health Services Ltd share price gained 1.96% to Rs 620.65 after the company's net profit surged by 69.04% to Rs 56.07 crore, while revenue from operations improved marginally 8.38% to Rs 2037.11 crore in Q3FY26 over Q2FY26.


The market capitalization of Pharmacy Retail industry group stocks on BSE stood at Rs 13994.33 crore, rising 4.96%. It has inched up 4.19% over last one week and crept higher by 2.35% in last one month while the market capitalization of Medplus Health Services Ltd has marginally improved by 3.61% and 13.94% in the same period respectively.


Profit before tax (PBT) of Medplus Health Services Ltd stood at Rs 70.15 crore in Q3 FY26, gaining 1.76% year-on-year, and surging by 67.50% quarter-on-quarter. EBITDA came in at Rs 150 crore, rising by 13.80% YoY and jumping 31.83% sequentially.


Total expenses posted a minor rise of 6.94% to Rs 1950.89 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 21.26 crore, posting a minor increase of 2.90% YoY, while employee benefits expense was at Rs 250.04 crore, easing 3.36% YoY.


For the TTM ended FY26, revenue from operations advanced 12.33% to Rs 6892.47 crore, while net profit jumped 46.18% to Rs 219.61 crore, compared to previous TTM. EBITDA jumped by 47051% to Rs 536.05 crore, and PBT surged 50.22% to Rs 275.33 crore compared to previous TTM.


The company's consolidated net cash flow from operating activities stood at Rs 495.58 crore in FY26, as against Rs 540.43 crore in FY25.


Medplus Health Services Ltd tumbled by 19.80% in last one year, underperforming the benchmark BSE Sensex which has slipped by 13.18% during the same period.